Aclaris Therapeutics (ACRS) Change in Inventory (2018 - 2019)
Aclaris Therapeutics' (ACRS) quarterly Change in Inventory came in at -$3000.0 in Q4 2019, up 99.74% year-on-year from -$1502.0 in Q4 2018, and down 175.0% quarter-over-quarter from $4000.0 in Q3 2019.
Aclaris Therapeutics (ACRS) Change in Inventory (2018 - 2019) Analysis & Trends
Aclaris Therapeutics' Change in Inventory history runs 2 years deep, the most recent figure standing at -$3000.0 for Q4 2019.
- On a quarterly basis, Change in Inventory rose 99.74% year-over-year to -$3000.0 in Q4 2019; TTM through Dec 2019 was -$605000.0, a N/A change from a year earlier, with the FY2019 full-year figure at -$605000.0, down 493.14% from the prior year.
- Change in Inventory fell to -$3000.0 in Q4 2019 per ACRS's latest filing, from $4000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $65000.0 in Q1 2019 and bottomed at -$1.1 million in Q4 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 71.84 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 97.70 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -26.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Aclaris Therapeutics | 705.88 Mn | 705.88 Mn | 1.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -3,000.00 |
| Dec 31, 2019 | -3,000.00 |
| Sep 30, 2019 | 4,000.00 |
| Sep 30, 2019 | 4,000.00 |
| Jun 30, 2019 | -671,000.00 |
| Jun 30, 2019 | -671,000.00 |
| Mar 31, 2019 | 65,000.00 |
| Mar 31, 2019 | 65,000.00 |
| Dec 31, 2018 | -1.15 Mn |
| Dec 31, 2018 | -1.15 Mn |
| Sep 30, 2018 | 18,000.00 |
| Sep 30, 2018 | 18,000.00 |